IP Library › Granted Patent US 12,128,031
Granted Patent B2
US 12,128,031 · App. 18/206,559 · Granted Oct 29, 2024

Method of improving psychosocial health

Inventor: Alon Seifan (New York, NY)
Assignee: HB Biotech, Inc.
A61K31/4184A61K31/277A61K33/08A61K45/06A61P25/22A61P25/28
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,128,031
App. No.
18/206,559
Granted
Oct 29, 2024
Kind
B2
Abstract

As described below, the present invention features compositions and methods for treating brain and/or behavioral health disorders and their associated symptoms.

Claims (10)

1. A method of improving psychosocial health in a human in need thereof, the method comprising:

orally administering an effective amount of a calcium channel blocker (CCB) selected from the group consisting of anipamil, devapamil, falipamil, gallopamil, tiapamil, and verapamil; and

orally co-administering an effective amount of an angiotensin II receptor blocker (ARB) selected from the group consisting of telmisartan and candesartan; and

wherein the human is in need of improvement in three or more factors of psychosocial health selected from the group consisting of (i) meaning and purpose, (ii) emotional support, (iii) instrumental support, (iv) friendship, and (v) loneliness; and

wherein the human does not have a neurodegenerative disorder.

2. The method of claim 1 , wherein the ARB is telmisartan.

3. The method of claim 1 , wherein the effective amount of the CCB is from about 120 mg to about 720 mg and the effective amount of the second agent ARB is from about 45 mg to about 180 mg.

4. The method of claim 3 , wherein (i) the CCB is verapamil, (ii) the effective amount of the CCB is 120-360 mg, (iii) the ARB is telmisartan, and (iv) the effective amount of the ARB is 40-180 mg.

5. The method of claim 1 , further comprising orally co-administering to the human an effective amount of magnesium oxide.

6. The method of claim 1 , wherein the effective amount of the CCB is administered once or twice daily and the effective amount of the ARB is administered once or twice daily.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 17, 2024
From: SEIFAN, ALON
To: HONEYBRAINS, LLC
Reel/Frame 068009/0814 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 17, 2024
From: HONEYBRAINS, LLC
To: HB BIOTECH, INC.
Reel/Frame 068009/0840 →
Continuity (4)
Continuation 17996413
Provisional Application 63111156 · Nov 9, 2020
Provisional Application 63011932 · Apr 17, 2020
Related Publication 20230310383A1 · Oct 5, 2023